Can Centene Stock Stage a Comeback After a Brutal Year?
Published on 11/09/2025 at 11:43 | Redaktion boerse-global.de
Centene shares have endured a punishing period in the markets, plummeting over 40% year-to-date. However, the healthcare giant’s latest quarterly report suggests a potential inflection point may be approaching. While grappling with a multi-billion dollar impairment charge, the company delivered a powerful performance that significantly exceeded revenue and earnings forecasts.
The third quarter revealed a company delivering robust operational growth despite significant accounting headwinds. Centene’s revenue surged to $49.69 billion, representing an impressive 18.2% year-over-year increase that beat analyst projections by 4.4%. This positive surprise propelled the stock upward by 6.2% following the announcement.
However, these results were overshadowed by a substantial non-cash goodwill impairment charge of $6.7 billion. This Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
